Thursday, May 23, 2024

The 561 Face of Alzheimer’s Prevention and Treatment

Paayal K. Patel, MD 
Brain Matters Research 

“In this day and age, we’re able to target patients with genetic risk factors or early evidence of Alzheimer’s disease, and try to either delay or prevent it completely,” says Neurologist Dr. Paayal Patel of Brain Matters Research. 

“We don’t have a way to reverse what’s already happened in the brain, because we don’t have a cure just yet, but two new FDA-approved medications are helping to either stabilize or reduce the rate of decline both cognitively and functionally,” she says optimistically. 

“We are also conducting a new research study that is giving people living with Alzheimer’s disease a different treatment option. The HOPE Study is investigating the capability of a new, wearable headset device to potentially slow the progression of mild to moderate Alzheimer’s disease, and people can participate in the study from the comfort of their own home.” 

Unlike at most medical offices, patients at Brain Matters have the option for a complimentary memory screening called Know in 90, a program where patients can be evaluated, as long as they’re open to the prospect of treatment through research and to learning more about what health treatments are available. This involves basic cognitive testing, and meeting with all the staff to provide basic history about cognitive changes they’ve been experiencing, or concerns loved ones have observed in terms of cognitive functional decline. “Then they get to meet with myself or Dr. Brody to discuss the treatment options. Above all, our patients’ safety is our main concern,” Dr. Patel emphasizes. 

BRAIN MATTERS RESEARCH 
561-374-8461 
brainmattersresearch.com 

This sponsored content is from the November/December 2023 issue of Boca magazineFor more from this year’s 561 Faces special section, click here.

Related Articles

Latest Articles